Jeffrey E. Lehr

587 total citations
9 papers, 494 citations indexed

About

Jeffrey E. Lehr is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeffrey E. Lehr has authored 9 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeffrey E. Lehr's work include Nuclear Structure and Function (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Jeffrey E. Lehr is often cited by papers focused on Nuclear Structure and Function (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Jeffrey E. Lehr collaborates with scholars based in United States and Netherlands. Jeffrey E. Lehr's co-authors include Kenneth J. Pienta, Nguyet Minh Nguyen, Ruey Chen, Herbert D. Soule, Vivianne C. G. Tjan‐Heijnen, Peggy Manders, Fred C.G.J. Sweep, Paul N. Span, Michael J. Mahoney and Kosuke Yamazaki and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Urology and Breast Cancer Research and Treatment.

In The Last Decade

Jeffrey E. Lehr

9 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey E. Lehr United States 7 308 169 120 70 65 9 494
Rosie Xing Canada 9 322 1.0× 130 0.8× 85 0.7× 226 3.2× 51 0.8× 12 558
Danielle L. Jernigan United States 9 315 1.0× 225 1.3× 103 0.9× 143 2.0× 43 0.7× 11 553
Bowden Gt United States 10 242 0.8× 201 1.2× 91 0.8× 221 3.2× 129 2.0× 14 497
E L Madison United States 8 276 0.9× 81 0.5× 82 0.7× 442 6.3× 66 1.0× 8 660
Jennie Hauser United States 9 332 1.1× 235 1.4× 85 0.7× 94 1.3× 62 1.0× 13 542
Moira Wood United States 8 356 1.2× 316 1.9× 78 0.7× 200 2.9× 30 0.5× 10 593
Antonio Candiloro Italy 11 415 1.3× 232 1.4× 30 0.3× 189 2.7× 52 0.8× 17 635
Ruth J. Muschel United States 7 333 1.1× 247 1.5× 55 0.5× 176 2.5× 26 0.4× 8 517
Brigitte Bisarò Italy 12 307 1.0× 172 1.0× 35 0.3× 103 1.5× 161 2.5× 16 513
Shi‐Ming Chang United States 6 285 0.9× 219 1.3× 354 3.0× 127 1.8× 44 0.7× 8 603

Countries citing papers authored by Jeffrey E. Lehr

Since Specialization
Citations

This map shows the geographic impact of Jeffrey E. Lehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey E. Lehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey E. Lehr more than expected).

Fields of papers citing papers by Jeffrey E. Lehr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey E. Lehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey E. Lehr. The network helps show where Jeffrey E. Lehr may publish in the future.

Co-authorship network of co-authors of Jeffrey E. Lehr

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey E. Lehr. A scholar is included among the top collaborators of Jeffrey E. Lehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey E. Lehr. Jeffrey E. Lehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Span, Paul N., et al.. (2006). High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Breast Cancer Research and Treatment. 98(2). 223–230. 29 indexed citations
2.
Lehr, Jeffrey E., et al.. (2000). The study of gemcitabine in combination with other chemotherapeutic agents as an effective treatment for prostate cancer.. PubMed. 20(2A). 735–40. 13 indexed citations
3.
Lehr, Jeffrey E., et al.. (1999). The isolation and characterization of epithelial cells from canine prostate.. PubMed. 18(6A). 4483–8. 3 indexed citations
4.
Lehr, Jeffrey E. & Kenneth J. Pienta. (1998). Preferential Adhesion of Prostate Cancer Cells to a Human Bone Marrow Endothelial Cell Line. JNCI Journal of the National Cancer Institute. 90(2). 118–123. 191 indexed citations
5.
Pienta, Kenneth J., et al.. (1996). Effect of estramustine, etoposide, and taxol on prostate cancer cell growth in vitro and in vivo. Urology. 48(1). 164–170. 33 indexed citations
6.
Yamazaki, Kosuke, Jeffrey E. Lehr, Johng S. Rhim, & Kenneth J. Pienta. (1996). Establishment of an immortalized Copenhagen rat bone marrow endothelial cell line.. PubMed. 10(4). 459–62. 3 indexed citations
7.
Pienta, Kenneth J., Nguyet Minh Nguyen, & Jeffrey E. Lehr. (1993). Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide.. PubMed. 53(2). 224–6. 135 indexed citations
8.
Pienta, Kenneth J. & Jeffrey E. Lehr. (1993). A common set of nuclear matrix proteins in prostate cancer cells. The Prostate. 23(1). 61–67. 11 indexed citations
9.
Lehr, Jeffrey E., et al.. (1993). Nuclear matrix proteins in normal and breast cancer cells.. PubMed. 53(14). 3394–8. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026